166 related articles for article (PubMed ID: 35609325)
21. The WNK1-ERK5 route plays a pathophysiological role in ovarian cancer and limits therapeutic efficacy of trametinib.
Sánchez-Fdez A; Matilla-Almazán S; Montero JC; Del Carmen S; Abad M; García-Alonso S; Bhattacharya S; Calar K; de la Puente P; Ocaña A; Pandiella A; Esparís-Ogando A
Clin Transl Med; 2023 Apr; 13(4):e1217. PubMed ID: 37029785
[TBL] [Abstract][Full Text] [Related]
22. Requirement of the MEK5-ERK5 pathway for neural differentiation in Xenopus embryonic development.
Nishimoto S; Kusakabe M; Nishida E
EMBO Rep; 2005 Nov; 6(11):1064-9. PubMed ID: 16179948
[TBL] [Abstract][Full Text] [Related]
23. Characterization of the MEK5-ERK5 module in human neutrophils and its relationship to ERK1/ERK2 in the chemotactic response.
Hii CS; Anson DS; Costabile M; Mukaro V; Dunning K; Ferrante A
J Biol Chem; 2004 Nov; 279(48):49825-34. PubMed ID: 15381709
[TBL] [Abstract][Full Text] [Related]
24. The Hedgehog-GLI Pathway Regulates MEK5-ERK5 Expression and Activation in Melanoma Cells.
Tusa I; Gagliardi S; Tubita A; Pandolfi S; Menconi A; Lulli M; Dello Sbarba P; Stecca B; Rovida E
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681917
[TBL] [Abstract][Full Text] [Related]
25. The MEK5/ERK5 signalling pathway in cancer: a promising novel therapeutic target.
Simões AE; Rodrigues CM; Borralho PM
Drug Discov Today; 2016 Oct; 21(10):1654-1663. PubMed ID: 27320690
[TBL] [Abstract][Full Text] [Related]
26. A kinome-wide high-content siRNA screen identifies MEK5-ERK5 signaling as critical for breast cancer cell EMT and metastasis.
Pavan S; Meyer-Schaller N; Diepenbruck M; Kalathur RKR; Saxena M; Christofori G
Oncogene; 2018 Aug; 37(31):4197-4213. PubMed ID: 29713055
[TBL] [Abstract][Full Text] [Related]
27. Biochanin A protects against PM
Xue Z; Wang J; Yu W; Li D; Zhang Y; Wan F; Kou X
Food Funct; 2019 Nov; 10(11):7188-7203. PubMed ID: 31608342
[TBL] [Abstract][Full Text] [Related]
28. Pathophysiological Impact of the MEK5/ERK5 Pathway in Oxidative Stress.
Tusa I; Menconi A; Tubita A; Rovida E
Cells; 2023 Apr; 12(8):. PubMed ID: 37190064
[TBL] [Abstract][Full Text] [Related]
29. Endoplasmic reticulum stress sensitizes pancreatic beta cells to interleukin-1β-induced apoptosis via Bim/A1 imbalance.
Miani M; Barthson J; Colli ML; Brozzi F; Cnop M; Eizirik DL
Cell Death Dis; 2013 Jul; 4(7):e701. PubMed ID: 23828564
[TBL] [Abstract][Full Text] [Related]
30. Upregulation of MEK5 by Stat3 promotes breast cancer cell invasion and metastasis.
Liu F; Zhang H; Song H
Oncol Rep; 2017 Jan; 37(1):83-90. PubMed ID: 27878304
[TBL] [Abstract][Full Text] [Related]
31. Activation of either ERK1/2 or ERK5 MAP kinase pathways can lead to disruption of the actin cytoskeleton.
Barros JC; Marshall CJ
J Cell Sci; 2005 Apr; 118(Pt 8):1663-71. PubMed ID: 15797923
[TBL] [Abstract][Full Text] [Related]
32. Genistein induces cell apoptosis in MDA-MB-231 breast cancer cells via the mitogen-activated protein kinase pathway.
Li Z; Li J; Mo B; Hu C; Liu H; Qi H; Wang X; Xu J
Toxicol In Vitro; 2008 Oct; 22(7):1749-53. PubMed ID: 18761399
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of mitogen-activated protein kinase signaling pathway sensitizes breast cancer cells to endoplasmic reticulum stress-induced apoptosis.
Yang F; Tang XY; Liu H; Jiang ZW
Oncol Rep; 2016 Apr; 35(4):2113-20. PubMed ID: 26796921
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of MEK5 by BIX02188 induces apoptosis in cells expressing the oncogenic mutant FLT3-ITD.
Razumovskaya E; Sun J; Rönnstrand L
Biochem Biophys Res Commun; 2011 Aug; 412(2):307-12. PubMed ID: 21820407
[TBL] [Abstract][Full Text] [Related]
35. BAFF activation of the ERK5 MAP kinase pathway regulates B cell survival.
Jacque E; Schweighoffer E; Tybulewicz VL; Ley SC
J Exp Med; 2015 Jun; 212(6):883-92. PubMed ID: 25987726
[TBL] [Abstract][Full Text] [Related]
36. Resistance to MAPK Inhibitors in Melanoma Involves Activation of the IGF1R-MEK5-Erk5 Pathway.
Benito-Jardón L; Díaz-Martínez M; Arellano-Sánchez N; Vaquero-Morales P; Esparís-Ogando A; Teixidó J
Cancer Res; 2019 May; 79(9):2244-2256. PubMed ID: 30833419
[TBL] [Abstract][Full Text] [Related]
37. Erk5 inhibits endothelial migration via KLF2-dependent down-regulation of PAK1.
Komaravolu RK; Adam C; Moonen JR; Harmsen MC; Goebeler M; Schmidt M
Cardiovasc Res; 2015 Jan; 105(1):86-95. PubMed ID: 25388666
[TBL] [Abstract][Full Text] [Related]
38. Regulation of cell survival by sphingosine-1-phosphate receptor S1P1 via reciprocal ERK-dependent suppression of Bim and PI-3-kinase/protein kinase C-mediated upregulation of Mcl-1.
Rutherford C; Childs S; Ohotski J; McGlynn L; Riddick M; MacFarlane S; Tasker D; Pyne S; Pyne NJ; Edwards J; Palmer TM
Cell Death Dis; 2013 Nov; 4(11):e927. PubMed ID: 24263101
[TBL] [Abstract][Full Text] [Related]
39. Novel roles for ERK5 and cofilin as critical mediators linking ERα-driven transcription, actin reorganization, and invasiveness in breast cancer.
Madak-Erdogan Z; Ventrella R; Petry L; Katzenellenbogen BS
Mol Cancer Res; 2014 May; 12(5):714-27. PubMed ID: 24505128
[TBL] [Abstract][Full Text] [Related]
40. SATB2 suppresses the progression of colorectal cancer cells via inactivation of MEK5/ERK5 signaling.
Mansour MA; Hyodo T; Ito S; Kurita K; Kokuryo T; Uehara K; Nagino M; Takahashi M; Hamaguchi M; Senga T
FEBS J; 2015 Apr; 282(8):1394-405. PubMed ID: 25662172
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]